CAMP4 THERAPEUTICS CORPORATION
+15.9% · 90d
$4.44
+0.00 (+0.00%)
After-Hours $4.44(+0.00)
News
(1)April 2026
CAMP Files Annual Report to Shareholders
CAMPCamp4 Therapeutics Corp
Based on the document provided, the actual content of the ARS (Annual Report to Shareholders) for Camp4 Therapeutics Corp is not visible in the text. The document appears to be a placeholder or index entry. However, I can explain what an ARS filing typically contains and what it means for you as an
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%